Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
Abroad (travel likely)Recruiting
Conditions
Coronavirus · Respiratory Infection · COVID
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Children's Hospital Los Angeles, Los Angeles, California, United States
Contact: Study coordinator (Jenn Dien Bard, PhD D(ABMM) F(CCM) · jdienbard@chla.usc.edu · (323) 361-5443George Washington University, Washington D.C., District of Columbia, United States
Tampa General Hospital, Tampa, Florida, United States
Emory University Hospital, Atlanta, Georgia, United States
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Contact: Study coordinator (John Williamson, PharmD) · john.williamson@advocatehealth.org · 336-716-2700University of Texas Medical Branch, Galveston, Texas, United States
Study leads
Brittany C Collins, PhD
Principal Investigator
BioFire Defense LLC